An anti-nuclear antibody test is used to detect antinuclear antibodies (ANA) in the blood. The immune system normally makes antibodies to help fight infection, as in normal conditions, the system recognizes foreign entities such as virus, and bacteria, and fight against these foreign particles. Some people have positive ANA tests even when they’re healthy. ANAs attack body’s own cells. Hence, these are called antinuclear, as these target the nucleus of cells. Antinuclear antibodies test is also used to help diagnose autoimmune disorders, such as Sjogren’s syndrome, scleroderma, rheumatoid arthritis, and systemic lupus erythematosus (a chronic condition that affects many parts of the body, such as joints, brain, blood vessels, and kidneys). Thus, these antibodies are crucial for the diagnosis and management of autoimmune disorders.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4469
Major players operating in the global anti-nuclear antibody testing market are Trinity Biotech Plc., Thermo Fisher Scientific, Inc., Inova Diagnostics, Immuno Concepts, EUROIMMUN AG, Antibodies, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Alere Inc., Zeus Scientific, Inc., ERBA Diagnostics, and F. Hoffmann-La Roche Ltd.
Key Market Drivers:
The outbreak of COVID-19 worldwide is expected to augment the growth of the anti-nuclear antibody testing market over the forecast period. For instance, in April 2020, Abbott announced the launch of COVID-19 antibody test, a lab-based serology blood test for the detection of the antibody, IgG, which identifies if a person has had the novel coronavirus (COVID-19). New test help determine if someone was infected and if the person has developed antibodies.
Moreover, increasing prevalence of autoimmune disorders worldwide is expected to aid in the growth of the anti-nuclear antibody testing market. Autoimmune diseases are a family of more than 80 chronic, life-threatening illnesses. For instance, according to the National Institutes of Health, around 23.5 million Americans (over 7% of the population) suffer from an autoimmune disease, and the prevalence is rising in this region.
COVID-19 Impact Analysis:
A positive antibody test shows that a person may have antibodies from a previous infection or from vaccination for the virus that causes COVID-19. COVID-19 antibody test, also known as serology test, look for antibodies to determine if an individual has had a past infection with the virus that causes COVID-19. COVID-19 antibody tests can help identify people who may have been infected with the virus or have recovered from the virus. Antibodies are proteins produced by the immune system in response to an infection. Currently, worldwide, many antibody tests are available or in development to detect COVID-19 antibodies. Antinuclear antibody test help detect, measure, and evaluate antinuclear antibodies in a patient’s blood sample. This in turn is expected to accelerate the growth of the market.
The anti-nuclear antibody testing market is expected to exhibit a CAGR of XX % during the forecast period owing to the introduction of novel products with advanced technologies coupled with recent approvals to diagnose for autoimmune diseases. For instance, in June 2018, U.S. Food and Drug Administration (FDA) approved Grifols’ HELIOS Automated System for the diagnosis of Lupus and ANCA-associated Vasculitis.
Among regions, Asia Pacific and North America are expected to witness significant growth in the anti-nuclear antibody testing market, owing to the increasing demand for anti-nuclear antibody testing and increasing prevalence of autoimmune disorders in this region. ANA test help diagnose and determine the type of autoimmune disorder. For instance, according to the American Autoimmune Related Diseases Association, Sjogren’s is a highly prevalent autoimmune disease, with an estimated 4 million cases in the U.S., making it the second most common autoimmune rheumatic disease in the country.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/4469
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027